Our collective findings highlight the Bit1/AES/TLE1 pathway as an important determinant of lung cancer progression, and hence its downregulation and/or inactivation [9] may contribute to lung cancer aggressiveness and metastasis. Here, PTRH2 is linked to lung carcinoma.